These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18462972)

  • 1. Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch Belted rabbits.
    García A; Marini RP; Catalfamo JL; Knox KA; Schauer DB; Rogers AB; Fox JG
    Microbes Infect; 2008 May; 10(6):650-6. PubMed ID: 18462972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli.
    Garcia A; Bosques CJ; Wishnok JS; Feng Y; Karalius BJ; Butterton JR; Schauer DB; Rogers AB; Fox JG
    J Infect Dis; 2006 Apr; 193(8):1125-34. PubMed ID: 16544253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
    Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
    Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A naturally occurring rabbit model of enterohemorrhagic Escherichia coli-induced disease.
    García A; Marini RP; Feng Y; Vitsky A; Knox KA; Taylor NS; Schauer DB; Fox JG
    J Infect Dis; 2002 Dec; 186(11):1682-6. PubMed ID: 12447748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli Infection.
    Mühlen S; Ramming I; Pils MC; Koeppel M; Glaser J; Leong J; Flieger A; Stecher B; Dersch P
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
    Gunzer F; Hennig-Pauka I; Waldmann KH; Sandhoff R; Gröne HJ; Kreipe HH; Matussek A; Mengel M
    Am J Clin Pathol; 2002 Sep; 118(3):364-75. PubMed ID: 12219778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncommon Shiga toxin-producing Escherichia coli serotype O165:HNM as cause of hemolytic uremic syndrome in São Paulo, Brazil.
    de Souza RL; Nishimura LS; Guth BE
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):223-5. PubMed ID: 17662558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of interleukin-10 reduces progression of shiga toxin-induced hemolytic uremic syndrome.
    Pineda GE; Rearte B; Todero MF; Bruballa AC; Bernal AM; Fernandez-Brando RJ; Isturiz MA; Zotta E; Alba-Soto CD; Palermo MS; Ramos MV
    Clin Sci (Lond); 2021 Feb; 135(3):575-588. PubMed ID: 33496327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.
    Zimmerhackl LB; Rosales A; Hofer J; Riedl M; Jungraithmayr T; Mellmann A; Bielaszewska M; Karch H
    Semin Thromb Hemost; 2010 Sep; 36(6):586-93. PubMed ID: 20865635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.
    Pohlenz JF; Winter KR; Dean-Nystrom EA
    Infect Immun; 2005 Jan; 73(1):612-6. PubMed ID: 15618202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.
    Fernandez GC; Lopez MF; Gomez SA; Ramos MV; Bentancor LV; Fernandez-Brando RJ; Landoni VI; Dran GI; Meiss R; Isturiz MA; Palermo MS
    Clin Exp Immunol; 2006 Oct; 146(1):76-84. PubMed ID: 16968401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.
    Stearns-Kurosawa DJ; Collins V; Freeman S; Tesh VL; Kurosawa S
    Infect Immun; 2010 Jun; 78(6):2497-504. PubMed ID: 20308301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of renal damage and tubular regeneration in pregnant and non-pregnant adult female rats inoculated with a sublethal dose of Shiga toxin 2.
    Fischer Sigel LK; Sánchez DS; Sacerdoti F; Zotta E; Silberstein C
    Microb Pathog; 2024 Jan; 186():106482. PubMed ID: 38086442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome.
    Brigotti M; Tazzari PL; Ravanelli E; Carnicelli D; Rocchi L; Arfilli V; Scavia G; Minelli F; Ricci F; Pagliaro P; Ferretti AV; Pecoraro C; Paglialonga F; Edefonti A; Procaccino MA; Tozzi AE; Caprioli A
    Pediatr Infect Dis J; 2011 Jun; 30(6):486-90. PubMed ID: 21164386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of complement in enterohemorrhagic Escherichia coli-Induced hemolytic uremic syndrome.
    Orth-Höller D; Würzner R
    Semin Thromb Hemost; 2014 Jun; 40(4):503-7. PubMed ID: 24799304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response.
    Karpman D; Ståhl AL
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement in typical hemolytic uremic syndrome.
    Orth D; Würzner R
    Semin Thromb Hemost; 2010 Sep; 36(6):620-4. PubMed ID: 20865638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.